Antidepressant-like actions of DOV 21,947: a “triple” reuptake inhibitor

Ainsworth, 1998, Effect of antidepressant drugs on dopamine D1 and D2 receptor expression and dopamine release in the nucleus accumbens of the rat, Psychopharmacology, 140, 470, 10.1007/s002130050791 Borsini, 1988, Is the forced swim test a suitable model for revealing antidepressant activity?, Psychopharmacology, 94, 147, 10.1007/BF00176837 Boukoms, 1993, Pergolide: an antidepressant adjuvant for mood disorders?, Psychopharmacol. Bull., 29, 207 Briley, 1997, Antidepressant properties of specific serotonin–noradrenaline reuptake inhibitors, 35 Corrigan, 2000, Comparison of pramipexole, fluoxetine, and placebo in patients with major depression, Depress. Anxiety, 11, 58, 10.1002/(SICI)1520-6394(2000)11:2<58::AID-DA2>3.0.CO;2-H D'Aquila, 2000, The role of dopamine in the mechanism of action of antidepressant drugs, Eur. J. Pharmacol., 405, 365, 10.1016/S0014-2999(00)00566-5 Dziedzicka Wasylewska, 1997, Repeated administration of antidepressant drugs affects the levels of mRNA coding for D1 and D2 dopamine receptors in the rat brain, J. Neural Transm., 104, 515, 10.1007/BF01277668 Eshleman, 1994, Release of dopamine via the human transporter, Mol. Pharmacol., 45, 312 Eshleman, 1995, Characterization of a recombinant human dopamine transporter in multiple cell lines, J. Pharmacol. Exp. Ther., 274, 276 Eshleman, 1999, Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type, J. Pharmacol. Exp. Ther., 289, 877 Galli, 1995, Sodium-dependent norepinephrine-induced currents in norepinephrine-transporter-transfected HEK-293 cells blocked by cocaine and antidepressants, J. Exp. Biol., 198, 2197, 10.1242/jeb.198.10.2197 Huthmann, 2000, Modification of a commercial chiral stationary phase: influences on enantiomer separation using simulated moving bed chromatography, J. Chromatogr., A, 908, 185, 10.1016/S0021-9673(00)00939-0 Izumi, 2000, Open pergolide treatment of tricyclic and heterocyclic antidepressant-resistant depression, J. Affect. Disord., 61, 127, 10.1016/S0165-0327(99)00199-8 Kent, 2000, SNaRIs, NASSAs, and NaRIs: new agents for the treatment of depression, Lancet, 355, 911, 10.1016/S0140-6736(99)11381-3 Lammers, 2000, Selective increase of dopamine D3 receptor gene expression as a common effect of chronic antidepressant treatments, Mol. Psychiatry, 5, 378, 10.1038/sj.mp.4000754 Layer, 1995, Antidepressant-like actions of the polyamine site NMDA antagonist, eliprodil (SL-82.0715), Pharmacol. Biochem. Behav., 52, 621, 10.1016/0091-3057(95)00155-P Naranjo, 2001, The role of the brain reward system in depression, Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 25, 781, 10.1016/S0278-5846(01)00156-7 Paul, 2001, Excitatory amino acid signalling, major depression and the actions of antidepressants, Pharm. News, 8, 33 Porsolt, 1992, Behavioral models of depression, 73 Porsolt, 1977, Depression: a new animal model sensitive to antidepressant treatments, Nature, 266, 730, 10.1038/266730a0 Porsolt, 1978, Behavioural despair in rats: a new model sensitive to antidepressant treatments, Eur. J. Pharmacol., 47, 379, 10.1016/0014-2999(78)90118-8 Ramamoorthy, 1993, Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization, Proc. Natl. Acad. Sci. U. S. A., 90, 2542, 10.1073/pnas.90.6.2542 Serra, 1979, Chronic treatment with antidepressant prevents the inhibitory effect of small doses of aopmorphine on dopamine synthesis and motor activity, Life Sci., 25, 414, 10.1016/0024-3205(79)90573-3 Sitland-Marken, 1990, Psychiatric applications of bromocriptine, J. Clin. Psychiatry, 51, 68 1997 Skolnick, 2002, Antidepressants beyond monoamine-based therapies: clues to new approaches, J. Clin. Psychiatry, 63, 19 Skolnick, 2002, Depression, 71 Skolnick, 2001, Current perspectives on the development of non-biogenic amine based antidepressants, Pharmacol. Res., 43, 411, 10.1006/phrs.2000.0806 Sporn, 2000, Pramipexole augmentation in the treatment of unipolar and bipolar depression: a retrospective chart review, Ann. Clin. Psychiatry, 12, 137, 10.3109/10401230009147102 Steru, 1985, The tail suspension test: a new method for screening antidepressants in mice, Psychopharmacology, 85, 367, 10.1007/BF00428203 Vetulani, 2000, Antidepressants: past, present and future, Eur. J. Pharmacol., 405, 351, 10.1016/S0014-2999(00)00565-3 Willner, 1997, Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation, Psychopharmacology, 134, 319, 10.1007/s002130050456 Willner, 2000, Dopaminergic mechanisms in depression and mania Zacharko, 1991, Stressor-induced anhedonia in the mesocorticolimbic system, Neurosci. Biobehav. Rev., 15, 391, 10.1016/S0149-7634(05)80032-6